Arcutis Biotherapeutics, Inc.  (Nasdaq: ARQT)
Arcutis Biotherapeutics, Inc.  (Nasdaq: ARQT)

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) Information

Contact top employees from Arcutis Biotherapeutics, Inc. (Nasda...

Summary

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a public company that has been in the industry for 9 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas. The position of the President & CEO is occupied by Frank Watanabe. Its headquarters is located at Westlake Village, California, USA. The number of employees ranges from 25 to 100. The Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) annual revenue is estimated at < 1M. Total funding of the company - $97.5M. To connect with Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) employee register on SignalHire.

Industries

Biotechnology

Headquarters Location

Employees Size

100-200 employees

Specialties

Biotechnology, Medical Dermatology, Drug Development, Inflammation, Immunology, Clinical Trials, Topical Drugs, Bioscience, Commercialization, Plaque Psoriasis, Atopic Dermatitis, Eczema

SIC Code

2834

DMA Code

Los Angeles Metropolitan Area

Founded

2016

Operating Status

Independent Company

Contact Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

Organization Website

Social Links

linkedIn

Phone Number

805-418-5006

Competitors

Founded
Type
Employees
Revenue
Funding
1948Public
Company
10K - 50K 16B $31.1M
2009Privately
Held
100 - 250 5M $148.1M
2014Privately
Held
25 - 100 6M $41.7M
2012Public
Company
25 - 100 5.2M $409.9M
2015Privately
Held
1 - 25 3M $4.7M
2016Public
Company
100 - 250 25.5M $41M
2013Public
Company
25 - 100 48M $168.7M
2014- 7 < 1M $41.2M
2004Public
Company
1.0K - 5.0K 25.4M $0
2001Public
Company
25 - 100 19M $0
2008Privately
Held
1 - 25 5.2M $0
2020Privately
Held
1.0K - 5.0K 1.2B $0
1981Privately
Held
1.0K - 5.0K 3.1B $0
-Privately
Held
1 - 25 10M $0
2003- 100-200 - $-
2014- 500-1000 - $-
2010- 100-200 - $-
-- 10-50 - $-

Estimated Website Traffic

The chart shows a growth in traffic to the arcutis.com website. In August, traffic increased to 38169, compared to 32022 in the previous month. The highest traffic in 2025 was recorded in August, reaching 38169 visits.

Employees Turnover 3 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Number of employees by department
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) shows a diverse range of experience levels:
2% have been with the company for less than 1 year17% for 1–2 years67% for 3–4 years8% for 5–7 years2% for 8–10 years5% have over 11 years of service at Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
Ex-employees positions
In Company
In New Company
Contact top employees from Arcutis Biotherapeutics, Inc. (Nasda...
Sandy Gates
Regional Sales Director, Mid-Atlantic
View
Steve Neder
Overlay Therapeutic Sales Specialist
View
Wendy Wilkins MBA
Executive Director of Accounting & Financial Reporting
View
Hersh Joshi
Senior Medical Science Liaison
View
Suzanne Magante
Associate Director, Medical Affairs Operations
View
Blake Workman
Director, Professional Relations
View
Mona De Silva
Therapeutic Sales Specialist
View
Diana Santarose
Overlay Therapeutic Sales Specialist
View
Shannon Boston
Associate Director, Meetings & Conventions
View
Samuel Jones
Therapeutic Sales Specialist
View
Daniel Byrnes
Executive Director Market Access Operations
View
Samantha DeBolske
Territory Sales Specialist
View
Emily Shupe
Principal Medical Science Liaison
View
Julie Dalsis
Regional Sales Director, Great Lakes
View
Margaret Fields
Overlay Therapeutic Sales Specialist
View
Jessi James
Director of HCP Marketing - Dermatology
View
Rajvir Madan
SVP and Chief Digital and Information Technology Officer
View
Xiangyi Meng
Executive Director, Head of Biostatistics and Head of Statistical Programming
View
Thomas Popovich
Associate Director Accounting
View
Jeffrey Greenberg
Executive Director, Training & Development, Sales - Commercial
View
Catherine Levy
Area Sales Director, East
View
Scott Snyder
Vice President, Patient Safety and Pharmacovigilance
View
Theresa Rice Haughey
Executive Director R&D Quality
View
Zachary Cirelli
Director Business Intelligence
View
Madison Joseph
Corporate Communications Manager
View
Maria Clark
Therapeutic Sales Specialist
View
Aymen Waqar
Director, Market Insights & Forecasting
View
Joanna King
Therapeutic Sales Specialist
View
Christian Picone
Therapeutic Sales Specialist
View
Jess Williams
Regional Account Director
View

FAQ

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) operates in the Biotechnology industries. More details can be found on the official website: arcutis.com.
The headquarters of Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) are located in Westlake Village, United States.
The current CEO of Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is Frank Watanabe
You can contact Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) by phone at 805-418-5006.
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) currently employs 100-200 people.
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)'s revenue is approximately < 1M.
Well-known competitors of Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) include Forest Laboratories (now Allergan), Suneva Medical, Azitra Inc and Aclaris Therapeutics, Inc..
BACK TO TOP